<DOC>
	<DOCNO>NCT00006132</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine efficacy long term suppressive therapy oral acyclovir infant herpes simplex virus infection involve central nervous system . II . Determine whether neurologic outcome improve patient treated regimen . III . Determine whether continuous administration drug suppress recurrent skin lesion patient . IV . Determine safety regimen patient .</brief_summary>
	<brief_title>Phase III Randomized Study Oral Acyclovir Infants With Herpes Simplex Virus Infection Involving Central Nervous System</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients stratify accord disease ( CNS disease without cutaneous involvement v disseminate disease CNS involvement ) . All patient receive acyclovir IV every 8 hour day 1-21 . On day 19 , patient undergo lumbar puncture must negative CSF PCR randomize . If patient positive CSF PCR day 19 , continue receive acyclovir IV every 8 hour . Treatment continue every 7 day repeat CSF PCR fifth day negative CSF PCR result achieve . Patients randomize one two treatment arm . Arm I : Patients receive oral acyclovir three time day 6 month . Arm II : Patients receive placebo . In case cutaneous recurrence first 12 month study , patient receive open label oral acyclovir ( CSF PCR negative ) acyclovir IV ( CSF PCR positive ) 5 day . Patients may may continue study drug follow treatment . Patients follow 6 , 12 , 24 , 36 , 48 , 60 month age .</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Infants diagnose herpes simplex virus infection involve central nervous system without evidence viral dissemination organ ( i.e. , skin , liver , lung ) HSV1 HSV2 isolate cutaneous lesion site ( skin , oropharynx , cerebrospinal fluid ( CSF ) , urine , etc . ) OR Must positive CSF polymerase chain reaction ( PCR ) cutaneous skin lesion present viral culture negative No infection limit skin , eye , mouth Evidence CNS involvement include one following : Abnormal CSF index term infant ( WBC great 22/mm3 protein great 115 mg/dL ) Abnormal CSF index preterm infant ( WBC great 25/mm3 protein great 220 mg/dL ) Abnormal neuroimaging study ( CT contrast , MRI gadolinium , head ultrasound ) Disseminated disease define one following : SGPT least 2.5 time upper limit normal Pneumonia/pneumonitis Necrotizing enterocolitis Disseminated intravascular coagulopathy Birth weight least 800 grams Prior/Concurrent Therapy No concurrent nurse mother receive acyclovir , valacyclovir , famciclovir longer 120 hour 5 day Patient Characteristics Renal : Creatinine great 1.5 mg/dL Cardiovascular : No prior grade 3 4 intraventricular hemorrhage Other : No infant know born HIV positive woman</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>herpes simplex virus infection</keyword>
	<keyword>herpes virus infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>viral infection</keyword>
</DOC>